MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Refreshing Day

<< Previous

Bullboard Posts

Next >>

Comment by swervon Apr 02, 2021 12:14am

270 Views

Post# 32931180

RE:RE:Refreshing Day

Then i found this in a search, but can't find the full release.

HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira ... has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for SARS-CoV-2 screening... CTI ...

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand